A Test in Context Critical Evaluation of Natriuretic Peptide Testing in Heart Failure

被引:49
作者
Francis, Gary S. [1 ]
机构
[1] Univ Minnesota, Div Cardiovasc, 420 Delaware St,MMC508, Minneapolis, MN 55455 USA
关键词
biological markers; BNP; neprilysin; NT-proBNP; PROGNOSTIC VALUE; VAL-HEFT; MORTALITY; TRIAL; DISCHARGE; THERAPY; BNP; ASSOCIATION; POPULATION; GUIDELINES;
D O I
10.1016/j.jacc.2015.10.073
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Circulating natriuretic peptide measurements have been used extensively over the past 15 years to diagnose and monitor patients with heart failure. We are still learning how complex the dynamics of natriuretic peptides can be in the interpretation of test results in individual patients. Although natriuretic peptide measurements are widely used in practice, there are questions regarding why these peptides may not necessarily track with blood volume or invasive hemodynamic measurements in individual patients. Interpretation of natriuretic peptide measurements will depend on many factors, including special patient populations, obesity, renal function, the state of congestion or decongestion, and whether patients are receiving specific therapies. Natriuretic peptide measurements have clearly revolutionized clinical care for patients with heart failure, but further research should provide insights to help use these measurements to individualize patient care beyond the current guidelines. (C) 2016 by the American College of Cardiology Foundation.
引用
收藏
页码:331 / 337
页数:7
相关论文
共 41 条
[1]   RELEASE OF ATRIAL NATRIURETIC PEPTIDE-LIKE IMMUNOREACTIVE MATERIAL DURING STRETCHING OF THE RAT ATRIUM INVITRO [J].
AGNOLETTI, G ;
RODELLA, A ;
FERRARI, R ;
HARRIS, P .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1987, 19 (03) :217-220
[2]   Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction Findings From the I-PRESERVE Trial [J].
Anand, Inder S. ;
Rector, Thomas S. ;
Cleland, John G. ;
Kuskowski, Michael ;
McKelvie, Robert S. ;
Persson, Hans ;
McMurray, John J. ;
Zile, Michael R. ;
Komajda, Michel ;
Massie, Barry M. ;
Carson, Peter E. .
CIRCULATION-HEART FAILURE, 2011, 4 (05) :569-577
[3]   Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) [J].
Anand, IS ;
Fisher, LD ;
Chiang, YT ;
Latini, R ;
Masson, S ;
Maggioni, AP ;
Glazer, RD ;
Tognoni, G ;
Cohn, JN .
CIRCULATION, 2003, 107 (09) :1278-1283
[4]   N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients [J].
Bettencourt, P ;
Azevedo, A ;
Pimenta, J ;
Frioes, F ;
Ferreira, S ;
Ferreira, A .
CIRCULATION, 2004, 110 (15) :2168-2174
[5]   Increasing B-type natriuretic peptide levels predict mortality in unselected haemodialysis patients [J].
Breidthardt, Tobias ;
Kalbermatter, Stefan ;
Socrates, Thenral ;
Noveanu, Markus ;
Klima, Theresia ;
Mebazaa, Alexandre ;
Mueller, Christian ;
Kiss, Denes .
EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (08) :860-867
[6]   EFFECTS OF SYNTHETIC ATRIAL NATRIURETIC FACTOR ON RENAL-FUNCTION AND RENIN RELEASE [J].
BURNETT, JC ;
GRANGER, JP ;
OPGENORTH, TJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 247 (05) :F863-F866
[7]   ATRIAL-NATRIURETIC-PEPTIDE ELEVATION IN CONGESTIVE-HEART-FAILURE IN THE HUMAN [J].
BURNETT, JC ;
KAO, PC ;
HU, DC ;
HESER, DW ;
HEUBLEIN, D ;
GRANGER, JP ;
OPGENORTH, TJ ;
REEDER, GS .
SCIENCE, 1986, 231 (4742) :1145-1147
[8]   Utility of Traditional Circulating and Imaging-Based Cardiac Biomarkers in Patients with Predialysis CKD [J].
Colbert, Gates ;
Jain, Nishank ;
de Lemos, James A. ;
Hedayati, S. Susan .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (03) :515-529
[9]   Impact of body mass and body composition on circulating levels of natriuretic peptides - Results from the Dallas heart study [J].
Das, SR ;
Drazner, MH ;
Dries, DL ;
Vega, GL ;
Stanek, HG ;
Abdullah, SM ;
Canham, RM ;
Chung, AK ;
Leonard, D ;
Wians, FH ;
de Lemos, JA .
CIRCULATION, 2005, 112 (14) :2163-2168
[10]   Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure [J].
Davis, ME ;
Richards, AM ;
Nicholls, G ;
Yandle, TG ;
Frampton, CM ;
Troughton, RW .
CIRCULATION, 2006, 113 (07) :977-985